Sandu Pharmaceutical - Quarterly Results
14th Feb 2019

The sales figure stood at Rs. 141.85 millions for the December 2018 quarter. The mentioned figure indicates a growth of about 27.06% as compared to Rs. 111.64 millions during the year-ago period.A radical decline of -77.69% was reported in the net profit of the company for the quarter ended December 2018 to Rs. 0.85  millions from Rs. 3.81 millions.A decline of 5.79 millions was observed in the OP in the quarter ended December 2018 from 9.74 millions on QoQ basis.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201812 201712 % Var 201812 201712 % Var 201803 201703 % Var
Sales 141.85 111.64 27.06 375.04 354.30 5.85 491.60 436.71 12.57
Other Income 1.24 0.08 1450.00 4.34 0.37 1072.97 1.22 3.92 -68.88
PBIDT 5.79 9.74 -40.55 21.46 16.65 28.89 25.88 23.22 11.46
Interest 2.36 3.04 -22.37 8.20 9.49 -13.59 12.31 14.94 -17.60
PBDT 3.44 6.70 -48.66 13.27 7.17 85.08 13.57 9.21 47.34
Depreciation 1.61 1.26 27.78 4.80 3.65 31.51 6.02 8.68 -30.65
PBT 1.83 5.45 -66.42 8.47 3.54 139.27 7.55 0.53 1324.53
TAX 0.99 1.64 -39.63 2.27 1.64 38.41 1.93 4.98 -61.24
Deferred Tax 0.51 0.00 0.00 0.08 0.00 0.00 -0.04 -1.62 -97.53
PAT 0.85 3.81 -77.69 6.22 1.90 227.37 5.62 -4.44 -226.58
Equity 70.81 70.81 0.00 70.81 70.81 0.00 70.81 70.81 0.00
PBIDTM(%) 4.09 8.73 -53.18 5.72 4.70 21.76 5.26 5.32 -0.99